Phase IV Multi-Institutional Randomized Trial of Capecitabine Plus Oxaliplatin With Bevacizumab in Patients With Potentially Resectable Gastric Cancer With Liver Metastasis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer; Liver metastases
- Focus Therapeutic Use
Most Recent Events
- 02 Mar 2017 New trial record